UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043213
Receipt number R000049320
Scientific Title a prospective trial of deep inspiration breath hold-intensity modulated radiotherapy for postoperative breast cancer
Date of disclosure of the study information 2021/02/01
Last modified on 2024/02/05 10:18:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

a prospective trial of deep inspiration breath hold-intensity modulated radiotherapy for postoperative breast cancer

Acronym

a prospective trial of DIBH-IMRT for postoperative breast cancer

Scientific Title

a prospective trial of deep inspiration breath hold-intensity modulated radiotherapy for postoperative breast cancer

Scientific Title:Acronym

a prospective trial of DIBH-IMRT for postoperative breast cancer

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

to evaluate the safety and effectiveness of deep inspiration breath hold-intensity modulated radiotherapy for left breast cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

acute and subacute adverse effects

Key secondary outcomes

late adverse effects, reduction of dose-volume histogram in risk organ comparing with 3D-CRT


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

42.4Gy/16fractions by deep inspiration breath hold-IMRT

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

1. postoperative left breast cancer
2. need postoperative radiotherapy
3. good performance status(ECOG PS0-1)
4. can breath hold more than 10 seconds
5. written informed consent

Key exclusion criteria

see left

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Keiichi
Middle name
Last name Jingu

Organization

Tohoku University Hospital

Division name

Department of Radiation Oncology

Zip code

9808574

Address

1-1 Seiryou-chou, Aobaku

TEL

0227177312

Email

kjingu-jr@rad.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Keiichi
Middle name
Last name Jingu

Organization

Tohoku University Hospital

Division name

Department of Radiation Oncology

Zip code

9808574

Address

Sendai

TEL

0227177312

Homepage URL


Email

kjingurad@yahoo.co.jp


Sponsor or person

Institute

Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

self

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

MHLW Certified Clinical Research Review Board, Tohoku University

Address

1-1 Seiryou-chou, Aobaku, Sendai

Tel

022-171-7000

Email

ec@rinri.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院(宮城県)


Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 01 Day


Related information

URL releasing protocol

https://pubmed.ncbi.nlm.nih.gov/38091980/

Publication of results

Published


Result

URL related to results and publications

https://pubmed.ncbi.nlm.nih.gov/38091980/

Number of participants that the trial has enrolled

25

Results

The evaluation of adverse events showed that three patients (12.0%) had Grade 2 radiation dermatitis. There was no other Grade 2 adverse event and there was no patient with an adverse event of Grade 3 or higher.

Results date posted

2024 Year 02 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2024 Year 01 Month 19 Day

Baseline Characteristics

Patients' characteristics
Age Median 47years
Performance status 0/1=25/0
pStage 0/IA/IB/IIA/IIB=2/16/0/6/1
Histology IDC/DCIS/others=21/2/2
Pathological tumor size Median=13.5mm
Boost Irradiation Yes/no=16/9

Participant flow

Twenty-five Japanese women were enrolled between February 2021 and November 2022 in this study. All of the enrolled patients completed the planned radiotherapy without interruption. Follow-up for 6 months or longer was performed for all of the enrolled patient.

Adverse events

Three patients (12.0%) had Grade 2 radiation dermatitis. There was no other Grade 2 adverse event and there was no patient with an adverse event of Grade 3 or higher.

Outcome measures

Those results confirmed our hypothesis that the experimental treatment method is non-inferior compared with our historical results. There was no patient with locoregional recurrence or metastases.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 01 Month 26 Day

Date of IRB

2021 Year 01 Month 26 Day

Anticipated trial start date

2021 Year 02 Month 01 Day

Last follow-up date

2023 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 02 Month 01 Day

Last modified on

2024 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049320


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name